Pacific Biosciences of California Inc. sell StockNews.com
Start price
12.03.24
/
50%
€3.86
Target price
12.03.25
-
Performance (%)
-64.30%
Price
26.04.24
€1.38
Summary
This prediction is currently active. Massive losses of -64.30% have been the result for the SELL prediction by StockNews_com. This prediction currently runs until 12.03.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacific Biosciences of California Inc. | -5.523% | -5.523% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by StockNews_com for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for PACB provided by MarketBeat
Stopped prediction by StockNews_com for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.39
18.04.24
18.04.24
-
18.04.25
18.04.25
-0.79%
26.04.24
26.04.24
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€5.85
13.01.24
13.01.24
-
13.01.25
13.01.25
-76.43%
26.04.24
26.04.24
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€9.37
29.12.23
29.12.23
-
29.12.24
29.12.24
-85.28%
26.04.24
26.04.24